إعلان
إعلان
VYNE
VYNE Therapeutics Inc. Common Stock
0.57
USDبرعاية
0.00
-0.19%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
0.58
+0.01
+1.58%
تقارير أرباح VYNE
النسبة الإيجابية المفاجئة
VYNE تفوق 20 من 32 آخر التقديرات.
63%
التقرير التالي
بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$204.00K
/-$0.18
التغير الضمني من Q3 25 (Revenue/ EPS)
+20.71%
/+5.88%
التغير الضمني من Q4 24 (Revenue/ EPS)
+142.86%
/-35.71%
VYNE Therapeutics Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, VYNE reported earnings of -0.17 USD per share (EPS) for Q3 25, missing the estimate of -0.13 USD, resulting in a -28.21% surprise. Revenue reached 169.00 ألف, compared to an expected 102.00 ألف, with a 65.69% difference. The market reacted with a +4.59% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -0.18 USD, with revenue projected to reach 204.00 ألف USD, implying an زيادة of 5.88% EPS, and زيادة of 20.71% in Revenue from the last quarter.
الأسئلة الشائعة
What were VYNE Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, VYNE Therapeutics Inc. Common Stock reported EPS of -$0.17, missing estimates by -28.21%, and revenue of $169.00K, 65.69% above expectations.
How did the market react to VYNE Therapeutics Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 4.59%, changed from $0.34 before the earnings release to $0.35 the day after.
When is VYNE Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
What are the forecasts for VYNE Therapeutics Inc. Common Stock's next earnings report?
Based on 5
المحللين, VYNE Therapeutics Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $204.00K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان